Henry James International Management’s Ascendis Pharma A/S ASND Stock Holding History

Henry James International Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.53M	Buy	16,987 +2,203	+15%	+$515K	1.36%	26
2026 Q1	$3.38M	Buy	14,784 +1,328	+10%	+$298K	1.22%	32
2025 Q4	$2.87M	Sell	13,456 -2,500	-16%	-$516K	0.9%	36
2025 Q3	$3.17M	Hold	15,956	–	–	0.97%	33
2025 Q2	$2.75M	Sell	15,956 -1,895	-11%	-$309K	0.91%	36
2025 Q1	$2.78M	Hold	17,851	–	–	0.95%	34
2024 Q4	$2.46M	Sell	17,851 -3,500	-16%	-$460K	0.88%	34
2024 Q3	$3.19M	Sell	21,351 -3,146	-13%	-$425K	1.11%	32
2024 Q2	$3.34M	Sell	24,497 -24	-0.1%	-$3.27K	1.18%	31
2024 Q1	$3.71M	Buy	24,521 +26	+0.1%	+$3.71K	1.14%	27
2023 Q4	$3.09M	Hold	24,495	–	–	1.16%	28
2023 Q3	$2.29M	Hold	24,495	–	–	0.99%	34
2023 Q2	$2.19M	Sell	24,495 -1,522	-6%	-$132K	0.95%	31
2023 Q1	$2.79M	Sell	26,017 -6	-0%	-$686	1.18%	27
2022 Q4	$3.18M	Hold	26,023	–	–	1.54%	25
2022 Q3	$2.69M	Buy	26,023 +2,701	+12%	+$256K	1.5%	25
2022 Q2	$2.17M	Sell	23,322 -6,400	-22%	-$603K	1.09%	31
2022 Q1	$3.49M	Sell	29,722 -7,177	-19%	-$831K	1.37%	27
2021 Q4	$4.96M	Hold	36,899	–	–	1.53%	23
2021 Q3	$5.88M	Buy	36,899 +1,355	+4%	+$185K	1.85%	16
2021 Q2	$4.68M	Buy	35,544 +60	+0.2%	+$8K	1.34%	23
2021 Q1	$4.57M	Sell	35,484 -3,299	-9%	-$501K	1.38%	22
2020 Q4	$6.47M	Hold	38,783	–	–	2.25%	12
2020 Q3	$5.99M	Buy	38,783 +1	+0%	+$144	2.44%	9
2020 Q2	$5.74M	Buy	38,782 +18,413	+90%	+$2.53M	2.4%	8
2020 Q1	$2.29M	Buy	20,369 +11,962	+142%	+$1.55M	1.18%	27
2019 Q4	$1.17M	Sell	8,407 -4,500	-35%	-$500K	0.45%	60
2019 Q3	$1.24M	Buy	12,907 +4,500	+54%	+$502K	0.53%	48
2019 Q2	$968K	Buy	8,407 +4,900	+140%	+$586K	0.42%	62
2019 Q1	$413K	Buy	+3,507	New	+$307K	0.19%	104

Other funds holding ASND

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

SAM

Synergy Asset Management Vancouver, Washington $1.06B AUM 36.26% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

SCM

Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

Henry James International Management's ASND Position: Q2 2026 in Review

Henry James International Management increased its Ascendis Pharma A/S (ASND) stake by 15% in Q2 2026, buying an estimated $515K and bringing the position to 16,987 shares worth $4.53M. The position accounts for 1.36% of the portfolio, ranked #26.

Henry James International Management first reported a position in ASND in Q1 2019 and has held it in 30 quarters since. The position peaked at $6.47M in Q4 2020. 59 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Henry James International Management held 16,987 shares of Ascendis Pharma A/S worth $4.53M as of Q2 2026.
Henry James International Management bought 2,203 Ascendis Pharma A/S shares in Q2 2026, an estimated $515K.
Ascendis Pharma A/S made up 1.36% of Henry James International Management's portfolio in Q2 2026, its #26 holding.
Henry James International Management first reported a position in Ascendis Pharma A/S in Q1 2019 and has held it in 30 quarters since.
Henry James International Management's Ascendis Pharma A/S position peaked at $6.47M in Q4 2020.
59 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Henry James International Management's 13F filing for Q2 2026, filed 9 Jul 2026.